Howard Wu

Company: Full Circles Therapeutics

Job title: Co-founder and CSO

Bio:

Passionate scientist with 13 years’ post-PhD Stem Cell, gene/epigenome editing and disease modelling both in vitro and in vivo. Experience supporting drug discovery functions in a startup team, lab setup experience and research team assembly. Broad drug discovery experience – including neurodevelopmental and neurodegenerative diseases and other neuromuscular and cardiac disorders, as well as haematology in rare genetic disease space. Strategically focused professional and team leader for disease indication selection and prioritization to fuel product engine. A valued point of contact for external KOLs and lead academic and industrial collaborations. His most recent venture has been building and fundraising for Full Circles Therapeutics, a gene editing biotech.

Seminars:

The Current Focus of Gene Editing: Applying Lessons from Ex-vivo Gene Editing to Inform In-vivo Innovations 10:00 am

An overview of Full Circle’s gene editing/writing platform technology Unpacking the successes in ex-vivo gene editing Exploring strategies to apply this platform technology to In-vivo applicationsRead more

day: GENE EDITING INNOVATION discussion day